Ambry Genetics and Invicro, Konica Minolta Companies
Ambry Genetics has been working with NGS platforms since 2007 and is both College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified. As a leader in clinical genetic diagnostics and genetics software solutions, Ambry combines both to offer the most comprehensive and highest quality testing solutions in the industry.
Invicro develops and leverages the latest approaches in quantitative biomarker research by providing a full range of image informatics, engineering and operational services to support drug discovery and development programs.